02-10-2021 12:32 PM | Source: Reuters
India`s Biological E looking to make 600 million J&J vaccine shots a year: CEO
NEW DELHI - Indian pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's COVID-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.
"We are targeting 600 million doses for J&J," said Datla. "This will be in addition to our own product for which we are targeting approximately 1 billion doses."
(Reporting by Krishna N. Das; Editing by Euan Rocha)
Latest News
Buy Crudeoil May @ 6850 SL 6750 TGT 6950-7050. MCX -...
Buy Cotton Candy May @ 58400 SL 58000 TGT 58800-5900...
NTPC rises on signing supplementary JVA-3 with NHPC,...
Buy Gold Jun @ 70800 SL 70600 TGT 71200-71400. MCX- ...
Buy Silver May @ 80200 SL 79500 TGT 81000-81500. MCX...
Buy Tata Elxsi Ltd For Target Rs. 8,095 - Choice Br...
Sell Aluminium May @ 238 SL 240 TGT 235-233. MCX - K...
Wardwizard Innovations & Mobility Limited appoints M...
In April, US business activity expanded at the slowe...
Vikas Lifecare surges as its agro business division ...